Dihydrokodein (Swedish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Dihydrokodein" in Swedish language version.

refsWebsite

Global rank Swedish rank

4^th place

17^th place

2^nd place

14^th place

5^th place

9^th place

399^th place

929^th place

2books.google.com

3^rd place

37^th place

2web.archive.org

1^st place

1^st place

18^th place

162^nd place

1chu-toulouse.fr

low place

low place

1,989^th place

446^th place

1mayoclinic.org

1,610^th place

682^nd place

1lakemedelsverket.se

low place

155^th place

books.google.com

(på engelska) Encyclopedia of Psychopharmacology. Springer Science & Business Media. 2010-07-31. ISBN 9783540686989. https://books.google.com/books?id=qoyYobgX0uwC.
(på engelska) Analogue-based Drug Discovery. John Wiley & Sons. 2006. Sid. 52X. ISBN 9783527607495. https://books.google.com/books?id=FjKfqkaKkAAC&pg=PA52X.

chu-toulouse.fr

”Equivalence table (in French)”. Equivalence table (in French). https://www.chu-toulouse.fr/IMG/pdf/12_table_conversion_palier_ii_et_iii_v5-2.pdf. Arkiverad 23 november 2015 hämtat från the Wayback Machine. ”Arkiverade kopian”. Arkiverad från originalet den 23 november 2015. https://web.archive.org/web/20151123190322/http://www.chu-toulouse.fr/IMG/pdf/12_table_conversion_palier_ii_et_iii_v5-2.pdf. Läst 8 november 2022.

doi.org

dx.doi.org

”The role of active metabolites in dihydrocodeine effects”. Int J Clin Pharmacol Ther 41 (3): sid. 95–106. 2003. doi:10.5414/cpp41095. PMID 12665158.
Leppert, Wojciech (2010-07-11). ”Dihydrocodeine as an opioid analgesic for the treatment of moderate to severe chronic pain”. Current Drug Metabolism 11 (6): sid. 494–506. doi:10.2174/138920010791636211. ISSN 1875-5453. PMID 20540693. https://pubmed.ncbi.nlm.nih.gov/20540693/.
Cowan, D. A.; Woffendin, G.; Noormohammadi, A. (1988). ”Two assays for dihydrocodeine in plasma and in urine and their use to determine the bioavailability of a controlled-release product”. Journal of Pharmaceutical Sciences 77 (7): sid. 606–609. doi:10.1002/jps.2600770711. ISSN 0022-3549. PMID 3171947. https://pubmed.ncbi.nlm.nih.gov/3171947/.
Di Girolamo, Guillermo; Opezzo, Javier A. W.; Lopez, Marcela I.; Schere, Daniel; Keller, Guillermo; Gonzalez, Claudio D.; Massa, Javier Martinelli; de los Santos, María Cecilia (2007). ”Relative bioavailability of new formulation of paracetamol effervescent powder containing sodium bicarbonate versus paracetamol tablets: a comparative pharmacokinetic study in fed subjects”. Expert Opinion on Pharmacotherapy 8 (15): sid. 2449–2457. doi:10.1517/14656566.8.15.2449. ISSN 1744-7666. PMID 17931082. https://pubmed.ncbi.nlm.nih.gov/17931082/.
Kim, Hyejeong; Park, Hanwook; Lee, Sang Joon (2017-08-29). ”Effective method for drug injection into subcutaneous tissue”. Scientific Reports 7 (1): sid. 9. doi:10.1038/s41598-017-10110-w. PMID 28852051. Bibcode: 2017NatSR...7.9613K.
Bailey, Chris P.; Connor, Mark (2005). ”Opioids: cellular mechanisms of tolerance and physical dependence”. Current Opinion in Pharmacology 5 (1): sid. 60–68. doi:10.1016/j.coph.2004.08.012. ISSN 1471-4892. PMID 15661627. https://pubmed.ncbi.nlm.nih.gov/15661627/.
Ashina, Kohei; Tsubosaka, Yoshiki; Nakamura, Tatsuro; Omori, Keisuke; Kobayashi, Koji; Hori, Masatoshi; Ozaki, Hiroshi; Murata, Takahisa (2015). ”Histamine Induces Vascular Hyperpermeability by Increasing Blood Flow and Endothelial Barrier Disruption In Vivo”. PLOS ONE 10 (7): sid. e0132367. doi:10.1371/journal.pone.0132367. ISSN 1932-6203. PMID 26158531. Bibcode: 2015PLoSO..1032367A.

drugs.com

”Myovant Sciences and Pfizer Receive U.S. FDA Approval of Myfembree, a Once-Daily Treatment for the Management of Moderate to Severe Pain Associated With Endometriosis” (på engelska). Drugs.com. https://www.drugs.com/newdrugs/myovant-sciences-pfizer-receive-u-s-fda-approval-myfembree-once-daily-management-moderate-severe-5872.html.
Multum, Cerner (2022-01-12). ”Acetaminophen, caffeine, and dihydrocodeine Uses, Side Effects & Warnings” (på engelska). Drugs.com. https://www.drugs.com/mtm/acetaminophen-caffeine-and-dihydrocodeine.html.
C., Fookes (2019-02-05). ”List of Common Antihistamines + Uses & Side Effects” (på engelska). Drugs.com. https://www.drugs.com/drug-class/antihistamines.html.
”Aspirin/caffeine/dihydrocodeine Side Effects: Common, Severe, Long Term” (på engelska). Drugs.com. https://www.drugs.com/sfx/aspirin-caffeine-dihydrocodeine-side-effects.html.

harvard.edu

adsabs.harvard.edu

Kim, Hyejeong; Park, Hanwook; Lee, Sang Joon (2017-08-29). ”Effective method for drug injection into subcutaneous tissue”. Scientific Reports 7 (1): sid. 9. doi:10.1038/s41598-017-10110-w. PMID 28852051. Bibcode: 2017NatSR...7.9613K.
Ashina, Kohei; Tsubosaka, Yoshiki; Nakamura, Tatsuro; Omori, Keisuke; Kobayashi, Koji; Hori, Masatoshi; Ozaki, Hiroshi; Murata, Takahisa (2015). ”Histamine Induces Vascular Hyperpermeability by Increasing Blood Flow and Endothelial Barrier Disruption In Vivo”. PLOS ONE 10 (7): sid. e0132367. doi:10.1371/journal.pone.0132367. ISSN 1932-6203. PMID 26158531. Bibcode: 2015PLoSO..1032367A.

lakemedelsverket.se

”Läkemedelsverkets föreskrifter (LVFS 1997:12) om förteckningar över narkotika, konsoliderad version t.o.m. LVFS 2010:1”. Arkiverad från originalet den 29 juni 2012. https://web.archive.org/web/20120629234352/http://www.lakemedelsverket.se/upload/lvfs/konsoliderade/LVFS_1997_12_konsoliderad_tom_2010_1.pdf. Läst 12 augusti 2010.

mayoclinic.org

”Irritable bowel syndrome - Symptoms and causes” (på engelska). Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/irritable-bowel-syndrome/symptoms-causes/syc-20360016.

nhs.uk

”Dihydrocodeine: painkiller” (på engelska). nhs.uk. 2019-10-25. https://www.nhs.uk/medicines/dihydrocodeine/.

nih.gov

ncbi.nlm.nih.gov

”The role of active metabolites in dihydrocodeine effects”. Int J Clin Pharmacol Ther 41 (3): sid. 95–106. 2003. doi:10.5414/cpp41095. PMID 12665158.
Leppert, Wojciech (2010-07-11). ”Dihydrocodeine as an opioid analgesic for the treatment of moderate to severe chronic pain”. Current Drug Metabolism 11 (6): sid. 494–506. doi:10.2174/138920010791636211. ISSN 1875-5453. PMID 20540693. https://pubmed.ncbi.nlm.nih.gov/20540693/.
Cowan, D. A.; Woffendin, G.; Noormohammadi, A. (1988). ”Two assays for dihydrocodeine in plasma and in urine and their use to determine the bioavailability of a controlled-release product”. Journal of Pharmaceutical Sciences 77 (7): sid. 606–609. doi:10.1002/jps.2600770711. ISSN 0022-3549. PMID 3171947. https://pubmed.ncbi.nlm.nih.gov/3171947/.
Di Girolamo, Guillermo; Opezzo, Javier A. W.; Lopez, Marcela I.; Schere, Daniel; Keller, Guillermo; Gonzalez, Claudio D.; Massa, Javier Martinelli; de los Santos, María Cecilia (2007). ”Relative bioavailability of new formulation of paracetamol effervescent powder containing sodium bicarbonate versus paracetamol tablets: a comparative pharmacokinetic study in fed subjects”. Expert Opinion on Pharmacotherapy 8 (15): sid. 2449–2457. doi:10.1517/14656566.8.15.2449. ISSN 1744-7666. PMID 17931082. https://pubmed.ncbi.nlm.nih.gov/17931082/.
Kim, Hyejeong; Park, Hanwook; Lee, Sang Joon (2017-08-29). ”Effective method for drug injection into subcutaneous tissue”. Scientific Reports 7 (1): sid. 9. doi:10.1038/s41598-017-10110-w. PMID 28852051. Bibcode: 2017NatSR...7.9613K.
Bailey, Chris P.; Connor, Mark (2005). ”Opioids: cellular mechanisms of tolerance and physical dependence”. Current Opinion in Pharmacology 5 (1): sid. 60–68. doi:10.1016/j.coph.2004.08.012. ISSN 1471-4892. PMID 15661627. https://pubmed.ncbi.nlm.nih.gov/15661627/.
Adriaensen, H.; Vissers, K.; Noorduin, H.; Meert, T. (2003). ”Opioid tolerance and dependence: an inevitable consequence of chronic treatment?”. Acta Anaesthesiologica Belgica 54 (1): sid. 37–47. ISSN 0001-5164. PMID 12703345. https://pubmed.ncbi.nlm.nih.gov/12703345/.
Ashina, Kohei; Tsubosaka, Yoshiki; Nakamura, Tatsuro; Omori, Keisuke; Kobayashi, Koji; Hori, Masatoshi; Ozaki, Hiroshi; Murata, Takahisa (2015). ”Histamine Induces Vascular Hyperpermeability by Increasing Blood Flow and Endothelial Barrier Disruption In Vivo”. PLOS ONE 10 (7): sid. e0132367. doi:10.1371/journal.pone.0132367. ISSN 1932-6203. PMID 26158531. Bibcode: 2015PLoSO..1032367A.
”Antihistamines”, LiverTox: Clinical and Research Information on Drug-Induced Liver Injury (Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases), 2012, PMID 31643232, http://www.ncbi.nlm.nih.gov/books/NBK547896/, läst 5 september 2022
Southard, Brittin T.; Al Khalili, Yasir (2022), ”Promethazine”, StatPearls (Treasure Island (FL): StatPearls Publishing), PMID 31335081, http://www.ncbi.nlm.nih.gov/books/NBK544361/, läst 5 september 2022
Canty, S. L. (May 1994). ”Constipation as a side effect of opioids”. Oncology Nursing Forum 21 (4): sid. 739–745. ISSN 0190-535X. PMID 8047473. https://pubmed.ncbi.nlm.nih.gov/8047473/.

pubmed.ncbi.nlm.nih.gov

Leppert, Wojciech (2010-07-11). ”Dihydrocodeine as an opioid analgesic for the treatment of moderate to severe chronic pain”. Current Drug Metabolism 11 (6): sid. 494–506. doi:10.2174/138920010791636211. ISSN 1875-5453. PMID 20540693. https://pubmed.ncbi.nlm.nih.gov/20540693/.
Cowan, D. A.; Woffendin, G.; Noormohammadi, A. (1988). ”Two assays for dihydrocodeine in plasma and in urine and their use to determine the bioavailability of a controlled-release product”. Journal of Pharmaceutical Sciences 77 (7): sid. 606–609. doi:10.1002/jps.2600770711. ISSN 0022-3549. PMID 3171947. https://pubmed.ncbi.nlm.nih.gov/3171947/.
Di Girolamo, Guillermo; Opezzo, Javier A. W.; Lopez, Marcela I.; Schere, Daniel; Keller, Guillermo; Gonzalez, Claudio D.; Massa, Javier Martinelli; de los Santos, María Cecilia (2007). ”Relative bioavailability of new formulation of paracetamol effervescent powder containing sodium bicarbonate versus paracetamol tablets: a comparative pharmacokinetic study in fed subjects”. Expert Opinion on Pharmacotherapy 8 (15): sid. 2449–2457. doi:10.1517/14656566.8.15.2449. ISSN 1744-7666. PMID 17931082. https://pubmed.ncbi.nlm.nih.gov/17931082/.
Bailey, Chris P.; Connor, Mark (2005). ”Opioids: cellular mechanisms of tolerance and physical dependence”. Current Opinion in Pharmacology 5 (1): sid. 60–68. doi:10.1016/j.coph.2004.08.012. ISSN 1471-4892. PMID 15661627. https://pubmed.ncbi.nlm.nih.gov/15661627/.
Adriaensen, H.; Vissers, K.; Noorduin, H.; Meert, T. (2003). ”Opioid tolerance and dependence: an inevitable consequence of chronic treatment?”. Acta Anaesthesiologica Belgica 54 (1): sid. 37–47. ISSN 0001-5164. PMID 12703345. https://pubmed.ncbi.nlm.nih.gov/12703345/.
Canty, S. L. (May 1994). ”Constipation as a side effect of opioids”. Oncology Nursing Forum 21 (4): sid. 739–745. ISSN 0190-535X. PMID 8047473. https://pubmed.ncbi.nlm.nih.gov/8047473/.

web.archive.org

”Equivalence table (in French)”. Equivalence table (in French). https://www.chu-toulouse.fr/IMG/pdf/12_table_conversion_palier_ii_et_iii_v5-2.pdf. Arkiverad 23 november 2015 hämtat från the Wayback Machine. ”Arkiverade kopian”. Arkiverad från originalet den 23 november 2015. https://web.archive.org/web/20151123190322/http://www.chu-toulouse.fr/IMG/pdf/12_table_conversion_palier_ii_et_iii_v5-2.pdf. Läst 8 november 2022.
”Läkemedelsverkets föreskrifter (LVFS 1997:12) om förteckningar över narkotika, konsoliderad version t.o.m. LVFS 2010:1”. Arkiverad från originalet den 29 juni 2012. https://web.archive.org/web/20120629234352/http://www.lakemedelsverket.se/upload/lvfs/konsoliderade/LVFS_1997_12_konsoliderad_tom_2010_1.pdf. Läst 12 augusti 2010.

worldcat.org

Leppert, Wojciech (2010-07-11). ”Dihydrocodeine as an opioid analgesic for the treatment of moderate to severe chronic pain”. Current Drug Metabolism 11 (6): sid. 494–506. doi:10.2174/138920010791636211. ISSN 1875-5453. PMID 20540693. https://pubmed.ncbi.nlm.nih.gov/20540693/.
Cowan, D. A.; Woffendin, G.; Noormohammadi, A. (1988). ”Two assays for dihydrocodeine in plasma and in urine and their use to determine the bioavailability of a controlled-release product”. Journal of Pharmaceutical Sciences 77 (7): sid. 606–609. doi:10.1002/jps.2600770711. ISSN 0022-3549. PMID 3171947. https://pubmed.ncbi.nlm.nih.gov/3171947/.
Di Girolamo, Guillermo; Opezzo, Javier A. W.; Lopez, Marcela I.; Schere, Daniel; Keller, Guillermo; Gonzalez, Claudio D.; Massa, Javier Martinelli; de los Santos, María Cecilia (2007). ”Relative bioavailability of new formulation of paracetamol effervescent powder containing sodium bicarbonate versus paracetamol tablets: a comparative pharmacokinetic study in fed subjects”. Expert Opinion on Pharmacotherapy 8 (15): sid. 2449–2457. doi:10.1517/14656566.8.15.2449. ISSN 1744-7666. PMID 17931082. https://pubmed.ncbi.nlm.nih.gov/17931082/.
Bailey, Chris P.; Connor, Mark (2005). ”Opioids: cellular mechanisms of tolerance and physical dependence”. Current Opinion in Pharmacology 5 (1): sid. 60–68. doi:10.1016/j.coph.2004.08.012. ISSN 1471-4892. PMID 15661627. https://pubmed.ncbi.nlm.nih.gov/15661627/.
Adriaensen, H.; Vissers, K.; Noorduin, H.; Meert, T. (2003). ”Opioid tolerance and dependence: an inevitable consequence of chronic treatment?”. Acta Anaesthesiologica Belgica 54 (1): sid. 37–47. ISSN 0001-5164. PMID 12703345. https://pubmed.ncbi.nlm.nih.gov/12703345/.
Ashina, Kohei; Tsubosaka, Yoshiki; Nakamura, Tatsuro; Omori, Keisuke; Kobayashi, Koji; Hori, Masatoshi; Ozaki, Hiroshi; Murata, Takahisa (2015). ”Histamine Induces Vascular Hyperpermeability by Increasing Blood Flow and Endothelial Barrier Disruption In Vivo”. PLOS ONE 10 (7): sid. e0132367. doi:10.1371/journal.pone.0132367. ISSN 1932-6203. PMID 26158531. Bibcode: 2015PLoSO..1032367A.
Canty, S. L. (May 1994). ”Constipation as a side effect of opioids”. Oncology Nursing Forum 21 (4): sid. 739–745. ISSN 0190-535X. PMID 8047473. https://pubmed.ncbi.nlm.nih.gov/8047473/.